c-Myc activation has been shown to lead to EZH2 overexpression by suppression of its negative regulatory miRNAs, such as miR-26 and miR-101, in NKTCL [26]. The gene discussed is EZH2; the disease is extranodal nasal NK/T cell lymphoma.